Clinical impact of immunomonitoring in the treatment of inflammatory bowel disease

Table 1 Detecting anti-tumor necrosis factor-α trough levels

Study	Technique	Key Points
Ternant et al[21]	ELISA
Vande Casteele et al[24]	ELISA
Lu et al[26]	FO-SPR based sandwich bioassay	Faster than ELISA, correlates well
Malíčková et al[27]	ELISA (for CT-P13 biosimiliar to infliximab)
Corstjens et al[28]	Rapid lateral flow (LF)-based assay
Wang et al[29]	Non-radiolabeled homogeneous mobility shift assay (HMSA)

ELISA: Enzyme-linked immunosorbent assay; FO-SPR: Fiber-optic surface plasmon resonance.